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Abstract
In a retrospective study of home infusion patients with central line-associated bloodstream 
infection, use of a central venous port, cancer diagnosis, and the absence of systemic inflammatory 
response syndrome were associated with use of catheter-salvage. Relapse of infection was 
uncommon.
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Background
The practice of home infusion has increased substantially in recent years, due in part to 
interest in minimizing inpatient length of stay and costs [1]. When a central line-associated 
bloodstream infection (CLABSI) is diagnosed in a home infusion patient, a treatment plan 
that retains the original intravenous catheter (catheter-salvage) may be given special 
consideration due to ongoing need for infusion therapy and preserving vascular access sites. 
For treatment of CLABSI in patients with a long-term central venous catheter, guidelines 
allow catheter-salvage in the absence of complications (tunnel infection, port abscess, septic 
thrombosis, endocarditis, or osteomyelitis) or certain pathogens such as S. aureus, and 
recommend catheter-salvage in patients requiring long-term intravascular access for survival 
[2]. The decision to use catheter-salvage in home infusion patients is important as this may 
potentially increase the risk of recurrent CLABSI when the need for vascular access is 
ongoing. It is not known what clinical factors, if any, may prompt the use of catheter-
salvage in the home infusion population. To better understand this decision, we performed a 
case-control study to evaluate the influence of clinical factors on the use of catheter-salvage 
in adult home infusion patients with CLABSI.
Methods
This was a retrospective case-control study of adult patients in the University of 
Pennsylvania’s home infusion therapy program who were treated for CLABSI from 7/1/08 
through 12/31/12. This study received expedited approval from the University of 
Pennsylvania’s Institutional Review Board.
Study Setting and Subjects
The diagnosis of CLABSI was determined using the Center for Disease Control and 
Prevention’s National Healthcare Safety Network surveillance definitions [3]. All patients in 
the home infusion database who underwent catheter-salvage for CLABSI (the catheter was 
left in place during and after treatment) were included as case subjects. Control subjects 
were selected from all database patients whose catheters were removed during treatment 
using a computer-generated random number sequence until a 3:1 ratio of controls to cases 
was reached. Exclusion criteria were death during hospitalization for CLABSI, hospice 
status, nonfunctional access device, a resolved need for home infusion therapy, CLABSI 
admission to a non-UPHS institution (due to lack of clinical data), and all recurrent 
CLABSIs.
Potential Catheter-Salvage Risk Factors
The following variables were examined at the time of CLABSI diagnosis: age, gender, 
disease category for home infusion therapy (hematologic/oncologic, gastrointestinal, other), 
Charlson Comorbidity Index [4], hospital admission date, admitting service (oncology, 
medicine, surgery), neutropenia (absolute neutrophil count less than 1,000/μL), presence of 
systemic inflammatory response syndrome (SIRS) [5] within 24 hours of admission, type of 
access device (peripherally-inserted central catheter, subcutaneous port, other), and 
organisms cultured from blood (S. aureus, other bacteria, or fungi).
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Statistical Analysis
The association of each variable with catheter-salvage was evaluated in a univariate 
analysis. Characteristics with univariate p-value < 0.2 were examined in a multivariate 
logistic regression model with the outcome of catheter salvage [6]. Nested models were 
compared with likelihood ratio testing, and non-nested models were compared with the 
Akaike Information Criteria [7]. For each comparison, we selected the model that best 
explained the outcome of interest using the fewest covariates [8]. All analyses were 
performed using STATA version 11 (StataCorp, College Station, TX).
Results
Patient Characteristics
CLABSI occurred in 263 home infusion patients during the study period. Catheter-salvage 
occurred in 34 patients (13.3%). After applying exclusion criteria, 31 patients remained in 
the salvage group (one was excluded for hospice status at time of CLABSI, and two were 
excluded for death during initial hospitalization). It was necessary to randomly select 122 
control patients to be left with 93 controls after applying exclusion criteria. Of the 24 
excluded control subjects, six were excluded for death during initial hospitalization, five for 
nonfunctional devices, and 13 for a resolved indication for home infusion.
Risk Factors for Catheter-Salvage
Clinical factors increasing the odds of catheter-salvage in univariate analyses included 
admission to an oncology service (OR 3.7, 95% CI [1.36, 10.06]) and presence of a port (OR 
5.26, 95% CI [1.62, 17.08]). The presence of SIRS criteria was strongly associated with 
catheter-removal (OR 0.29, 95% CI [0.12, 0.69]), as was gastrointestinal disease (OR 0.13, 
95% CI [0.03, 0.59], compared to hematologic/oncologic disease as a reference). Although 
all fungal CLABSIs were treated with catheter-removal, CLABSI due to S. aureus was not a 
risk factor for salvage or removal. Adjusted analysis showed associations between catheter-
salvage and hematologic/oncologic disease (adjusted OR {aOR} 11.03, 95% CI [2.13, 
56.99], p=0.004), port (aOR 4.29, 95% CI [1.08, 17.09], p=0.04), and SIRS criteria (aOR 
0.30, 95% CI [0.11, 0.85], p=0.02) (see Table). After treatment, the rate of CLABSI relapse 
was 12.9% in salvage patients and 7.5% in control patients (p=0.36). Among the four 
catheter-salvage patients with CLABSI due to S. aureus, no relapses occurred.
Discussion
In a device-associated infection such as CLABSI, treatment without removal of the device 
may increase the risk of recurrent infection. Thus, the initial management of CLABSI has 
implications for the prevention and incidence of future CLABSI episodes. In our 
investigation of CLABSI among home-infusion patients, hematologic/oncologic disease, 
subcutaneous port, and presence of SIRS independently affected the odds of catheter-
salvage. The port is a strong risk factor for catheter-salvage, likely because of the relative 
difficulty of removal. The negative effect of SIRS on catheter-salvage is in accordance with 
IDSA guidelines on the management of CLABSI in hemodynamically unstable patients [2]. 
The association between catheter-salvage and hematologic/oncologic disease is consistent 
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with our clinical experience but more difficult to explain. We suspect that patient comfort, 
length of stay, prognosis, and avoidance of delays in chemotherapy may influence the choice 
of catheter-salvage for an oncology patient with CLABSI. Notably, certain clinical factors, 
such as neutropenia, leukocytosis, ICU admission, and microbiology were not found to 
influence the odds of catheter-salvage. CLABSI recurrence was uncommon in both salvage 
and removal groups. Interestingly, in the four S. aureus patients in whom salvage was 
attempted, relapse did not occur.
This study had several limitations. As an observational study, we were able to control for 
potential confounding by measured variables only in the primary analysis. Furthermore, 
these findings may not be generalizable to populations without high proportions of oncology 
patients or subcutaneous port use.
In conclusion, certain clinical factors influenced the management of CLABSI in home 
infusion patients. For hemodynamically stable outpatients with CLABSI, catheter-salvage 
may be a safe and appropriate strategy. Additional studies are needed to prospectively 
evaluate the risks and long-term outcomes of catheter-salvage in a home infusion 
population.
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Table
Characteristics associated with catheter-salvage in home infusion patients with CLABSI.
Cases (n=31) Controls (n=93)
Univariate Analysis
Odds Ratio (95% CI) P value
Age category (%):
 <45 8 (26) 33 (35) Reference
 45–55 2 (6) 24 (26) 0.34 (0.07, 1.77) 0.20
 56–65 13 (41) 27 (29) 1.99 (0.72, 5.49) 0.19
 >65 8 (26) 9 (10) 3.67 (1.08, 12.50) 0.04
Male Sex (%) 15 (48) 41 (44) 1.19 (0.53, 2.69) 0.68
Admitting service (%):
 Hematology/Oncology 24 (77) 40 (43) Reference
 Medicine (non-Oncology) 6 (19) 37 (40) 0.27 (0.10, 0.73) 0.01
 Surgery 1 (3) 16 (17) 0.10 (0.01, 0.84) 0.03
Disease category (%):
 Hematology/Oncologya 28 (90) 53 (57) Reference
 Gastrointestinalb 2 (6) 29 (31) 0.13 (0.03, 0.59) 0.008
 Otherc 1 (3) 11 (12) 0.17 (0.02, 1.40) 0.10
Neutropenia (%) 7 (23) 13 (14) 1.79 (0.64, 5.01) 0.26
Leukocytosisd (%) 7 (23) 24 (26) 0.84 (0.32, 2.19) 0.72
SIRS criteriae (%) 10 (34) 60 (65) 0.29 (0.12, 0.69) 0.006
Intensive care admission (%) 2 (7) 12 (13) 0.5 (0.11, 2.38) 0.38
CCI, median (IQR) 5 (3–8) 4 (2–5) 1.25 (1.07, 1.45) 0.004
Access type (%):
 PICCf 18 (58) 71 (76) Reference
 Subcutaneous Port 8 (26) 6 (6) 5.26 (1.62, 17.08) 0.006
 Otherg 5 (16) 16 (17) 1.23 (0.40, 3.81) 0.72
Difficult access (%) 0 (0) 5 (5) Not defined --
Causative organism (%):
 Bacterial, not S. aureus 27 (87) 62 (67) Reference
 S. aureus 4 (13) 18 (19) 0.51 (0.16, 1.65) 0.26
 Fungal 0 (0) 13 (14) Not defined --
Multivariate Analysis
Odds Ratio (95% CI) P value
Age category:
 < 45 Reference
 45–55 0.23 (0.03, 2.14) 0.20
 56–65 2.67 (0.81, 8.85) 0.11
Am J Infect Control. Author manuscript; available in PMC 2015 December 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Caroff et al. Page 7
Cases (n=31) Controls (n=93)
Univariate Analysis
Odds Ratio (95% CI) P value
 >65 3.10 (0.65, 14.53) 0.16
Access type:
 PICC Reference
 Port 4.29 (1.08, 17.09) 0.04
 Other 2.30 (0.58, 9.07) 0.24
SIRS criteria met 0.30 (0.11, 0.85) 0.02
Hematology/Oncology disease 11.03 (2.13, 56.99) 0.004
aAll solid and liquid malignancies.
bShort gut syndrome and chronic bowel obstruction.
c
Infection, heart failure, pulmonary hypertension, hemophilia, and sickle cell anemia.
d
Leukocyte count greater than 11,000/μL.
eAt least two of the following: pulse >90/min, respirations >20/min, temperature >38.3°C or <36°C, leukocyte count >12,000 or <4,000 / μL, or 
>10% band forms.
f
Peripherally-inserted central catheter.
g
Hickman, trans-lumbar, and tunneled internal jugular catheters.
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